Revolutionizing Drug Discovery with Advanced Cell Painting Analysis

Introducing CellusAI – our ground-breaking AI platform purpose-built to refine and accelerate drug discovery processes utilizing the depth of information embedded in cell painting images. CellusAI facilitates immaculate image segmentation, precise profile extraction, and streamlined downstream processing, bolstering predictions of bioactivity, mechanism of action, and toxicity.


Advanced Analyses and Precision Results

CellusAI stands out with its state-of-the-art AI-driven tools tailored specifically for cell painting. It not only offers seamless image segmentation and profile extraction, but also dives deep into subsequent processing to predict molecular bioactivity, mechanism of action, and toxicity.

Our approach showcases an impressive performance boost when compared with traditional systems. For instance, CellusAI’s mechanism of action predictions and feature extraction surpass those of legacy methods, with data indicating more informative results and better prediction capabilities in downstream analyses.


Pioneering New Molecule Generation

One of the most groundbreaking features on the CellusAI roadmap is the New Molecule Generative AI module, which utilizes AI to generate chemical structures that are predicted to induce specific cell painting profiles.

This is not just about exploring new molecules; it’s about generating previously untested or non-patented chemical entities. Along with creation, this module will also evaluate various molecular properties, assessing feasibility of synthesis, the potential to cross the blood-brain-barrier, and even estimating toxicity levels.

It’s a revolutionary step towards creating new assets in the field of drug discovery.

Read more on how AI can transform your drug discovery process

AI in Phenotypic Profiling: Pioneering Early-Stage Drug Discovery through High-Throughput Image Analysis

In the realm of early-stage drug discovery, the quest to understand the intricate interplay between genes and observable traits, known as phenotypes, is pivotal. This understanding holds the key to discovering new therapeutic avenues and revolutionizing the treatment...

CellusAI to be Showcased at SLAS2024’s Innovation AveNEW

With our groundbreaking AI product, CellusAI, TK Analytics has been handpicked as an Innovation AveNEW company for the upcoming SLAS2024 International Conference and Exhibition in Boston, MA. This acceptance isn’t just an honor for us—it's a testament to the potential...

TK Analytics Partners with NVIDIA through the Inception Program

We're thrilled to announce that TK Analytics has been selected to join the NVIDIA Inception Program, a prestigious initiative designed to accelerate the growth of startups innovating in AI and data science. By aligning with NVIDIA, we don't just gain access to the...

Work with the best

Why Choose TK Analytics?

Our expertise lies at the intersection of AI, data management, and high-content screening. By partnering with us, you gain access to:

Cutting-edge AI Technology

We utilize the latest advancements in AI and machine learning to unlock the true potential of your HCS data, accelerating your drug discovery journey.

Domain Expertise

Our team of seasoned professionals will ensure that our services are tailored to your unique research needs.

Data Security and Confidentiality

We prioritize data security and confidentiality, providing a secure environment for your valuable research data.

Efficiency and Speed

We help you reduce the time and effort required for HCS data interpretation, allowing you to focus on making groundbreaking discoveries.